Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun;37(8):792-799.
doi: 10.1055/s-0040-1712103. Epub 2020 May 19.

Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries

Devin D Smith  1 , Jessica L Pippen  1 , Adebayo A Adesomo  2 , Kara M Rood  1 , Mark B Landon  1 , Maged M Costantine  1
Affiliations

Exclusion of Pregnant Women from Clinical Trials during the Coronavirus Disease 2019 Pandemic: A Review of International Registries

Devin D Smith et al. Am J Perinatol. 2020 Jun.

Abstract

Objective: Pregnant women have been historically excluded from clinical trials for nonobstetric conditions, even during prior epidemics. The objective of this review is to describe the current state of research for pregnant women during the coronavirus disease 2019 (COVID-19) pandemic.

Study design: We conducted a search of international trial registries for trials relating to the novel coronavirus. The eligibility criteria for each trial were reviewed for inclusion/exclusion of pregnant women. Relevant data were extracted and descriptive statistics were calculated for individual and combined data. The total number of trials from each registry were compared, as well as the proportions of pregnancy-related trials within each.

Results: Among 621,370 trials in the World Health Organization International Clinical Trials Registry, 927 (0.15%) were COVID-19 related. Of those, the majority (52%) explicitly excluded pregnancy or failed to address pregnancy at all (46%) and only 16 (1.7%) were pregnancy specific. When categorized by region, 688 (74.2%) of COVID-19 trials were in Asia, followed by 128 (13.8%) in Europe, and 66 (7.2%) in North America. Of the COVID-19 trials which included pregnant women, only three were randomized-controlled drug trials.

Conclusion: Approximately 1.7% of current COVID-19 research is pregnancy related and the majority of trials either explicitly exclude or fail to address pregnancy. Only three interventional trials worldwide involved pregnant women. The knowledge gap concerning the safety and efficacy of interventions for COVID-19 created by the exclusion of pregnant women may ultimately harm them. While "ethical" concerns about fetal exposure are often cited, it is in fact unethical to habitually exclude pregnant women from research.

Key points: · Pregnancy was excluded from past pandemic research.. · Pregnancy is being excluded from COVID-19 research.. · Exclusion of pregnant women is potentially harmful..

PubMed Disclaimer

Conflict of interest statement

None declared.

Figures

Fig. 1
Fig. 1
WHO registry breakdown by type. WHO, World Health Organization.
Fig. 2
Fig. 2
WHO registry trials by region. COVID, coronavirus disease; WHO, World Health Organization.
See this image and copyright information in PMC

References

    1. Blehar M C, Spong C, Grady C, Goldkind S F, Sahin L, Clayton J A.Enrolling pregnant women: issues in clinical researchWomen's Heal Issues2013. Doi: 10.1016/j.whi.2012.10.003 - PMC - PubMed
    1. Shields K E, Lyerly A D. Exclusion of pregnant women from industry-sponsored clinical trials. Obstet Gynecol. 2013;122(05):1077–1081. - PubMed
    1. Illamola S M, Bucci-Rechtweg C, Costantine M M, Tsilou E, Sherwin C M, Zajicek A. Inclusion of pregnant and breastfeeding women in research - efforts and initiatives. Br J Clin Pharmacol. 2018;84(02):215–222. - PMC - PubMed
    1. Mitchell A A, Gilboa S M, Werler M M, Kelley K E, Louik C, Hernández-Díaz S; National Birth Defects Prevention Study.Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008 Am J Obstet Gynecol 201120501510–5.1E9. - PMC - PubMed
    1. Ayad M, Costantine M M. Epidemiology of medications use in pregnancy. Semin Perinatol. 2015;39(07):508–511. - PMC - PubMed

MeSH terms